Expression of the vascular endothelial growth factor (VEGF) receptor gene, KDR, in hematopoietic cells and inhibitory effect of VEGF on apoptotic cell death caused by ionizing radiation - PubMed
- ️Sun Jan 01 1995
. 1995 Dec 1;55(23):5687-92.
Affiliations
- PMID: 7585655
Expression of the vascular endothelial growth factor (VEGF) receptor gene, KDR, in hematopoietic cells and inhibitory effect of VEGF on apoptotic cell death caused by ionizing radiation
O Katoh et al. Cancer Res. 1995.
Abstract
Vascular endothelial growth factor (VEGF) has been identified as a peptide growth factor specific for vascular endothelial cells. In this study, we demonstrated the expression of the KDR gene transcript, which encodes a cell surface receptor for VEGF, in normal human hematopoietic stem cells, megakaryocytes, and platelets as well as in human leukemia cell lines, HEL and CMK86. Moreover, we showed the expression of VEGF gene transcript in these normal fresh cells and cell lines. To elucidate biological functions of VEGF on hematopoiesis, we determined whether this growth factor has mitogenic activity to hematopoietic cells or the ability to suppress apoptotic cell death. The liquid culture and colony-formation assay revealed that VEGF suppressed apoptotic cell death of both CMK86 cells and normal hematopoietic stem cells caused by gamma-ray irradiation, although mitogenic activity of VEGF was not detected. The ability of VEGF to suppress apoptotic cell death was independent of the change of cell cycle distribution. These data suggest that VEGF may play an important role in survival or maintenance of hematopoietic stem cells due to the prevention of apoptotic cell death caused by some stresses such as ionizing radiation and that VEGF may give leukemia cells some abilities of resistance against radiotherapy in an autocrine or paracrine manner.
Similar articles
-
Kuramoto K, Uesaka T, Kimura A, Kobayashi M, Watanabe H, Katoh O. Kuramoto K, et al. Cancer Res. 2000 Jan 15;60(2):425-30. Cancer Res. 2000. PMID: 10667597
-
Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies.
Bellamy WT, Richter L, Frutiger Y, Grogan TM. Bellamy WT, et al. Cancer Res. 1999 Feb 1;59(3):728-33. Cancer Res. 1999. PMID: 9973224
-
Vascular endothelial growth factor: possible role in fetal development and placental function.
Cheung CY. Cheung CY. J Soc Gynecol Investig. 1997 Jul-Aug;4(4):169-77. J Soc Gynecol Investig. 1997. PMID: 9292845 Review.
-
Bellamy WT. Bellamy WT. Semin Oncol. 2001 Dec;28(6):551-9. doi: 10.1016/s0093-7754(01)90023-5. Semin Oncol. 2001. PMID: 11740808 Review.
Cited by
-
VEGF as a mediator of tumor-associated immunodeficiency.
Ohm JE, Carbone DP. Ohm JE, et al. Immunol Res. 2001;23(2-3):263-72. doi: 10.1385/IR:23:2-3:263. Immunol Res. 2001. PMID: 11444391 Review.
-
Vascular endothelial growth factor in ovarian cancer.
Hazelton DA, Hamilton TC. Hazelton DA, et al. Curr Oncol Rep. 1999 Sep;1(1):59-63. doi: 10.1007/s11912-999-0011-9. Curr Oncol Rep. 1999. PMID: 11122799 Review.
-
Komiya K, Enomoto H, Inoki I, Okazaki S, Fujita Y, Ikeda E, Ohuchi E, Matsumoto H, Toyama Y, Okada Y. Komiya K, et al. Arthritis Res Ther. 2005;7(6):R1158-73. doi: 10.1186/ar1796. Epub 2005 Aug 5. Arthritis Res Ther. 2005. PMID: 16277668 Free PMC article.
-
Cao HY, Tao T, Shen XD, Bai L, Wan CL, Wu DP, Li JL, Xue SL. Cao HY, et al. Clin Case Rep. 2022 Feb 3;10(2):e05367. doi: 10.1002/ccr3.5367. eCollection 2022 Feb. Clin Case Rep. 2022. PMID: 35140963 Free PMC article.
-
Attenuation of VEGFR-2 expression by sFlt-1 and low oxygen in human placenta.
Nevo O, Lee DK, Caniggia I. Nevo O, et al. PLoS One. 2013 Nov 19;8(11):e81176. doi: 10.1371/journal.pone.0081176. eCollection 2013. PLoS One. 2013. PMID: 24260556 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical